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Summary 
The WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) region has been as-
sigru~4.,tQ ~hromosome 11p13 on the basis of overlapping constitutional dele-tioas- found in affected individ-
uals. We have utilized 31 DNA probes which map to the WAGR deletion region, tagether with si.x refer-
ence loci and 13 WAGR-related deletions, to subdivide this area into 16 intervals. Specific intervals have 
been correlated with phenotypic features, leading to the identification of individual subregions for the 
aniridia and Wilms tumor loci. Delineation, by specific probes, of multiple intervals above and below the 
critical region and of five intervals within the overlap area provides a framework map for molecular char-
acterization of WAGR gene loci and of deletion boundary regions. 
lntroduction 
The WAGR (i.e., Wilms tumor, aniridia, genitourinary 
anomalies, and mental retardation) syndrome is as-
sociated with constitutional heterozygous deletions of 
the short arm of chromosome 11, with a common re-
gion of overlap at band p13 (Francke et al. 1979; Ric-
cardi et al. 1980; Shannon et al. 1982). Chromosomal 
deletions induding 11p13 have also been found in tu-
mor tissue of individuals with Wilms tumors and no 
additional features of the WAGR syndrome (Kaneko 
et al. 1981; Douglass et al. 1985). Furthermore, in two 
families with familial aniridia, this condition was as-
sociated with different chromosomal translocations, 
both involving llp13 (Simola et al. 1983; Moore et al. 
1986). This region is therefore assumed to contain a 
Wilms tumor gene, as weil as additional genes associated 
with the developmental malfonnations of the syndrome. 
The first marker mapped to the WAGR deletion re-
gion was the catalase gene (Junien et al. 1980), and 
reduced Ievels of erythrocyte catalase activity have been 
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observed in a number of individuals with these dele-
tions (Ferrell and Riccardi 1981; Junien et al. 1983 ). 
By use of molecularly cloned probes, the critical region 
could be narrowed down to an unmapped area between 
the catalase and the follicle-stimulating honnone beta-
subunit (FSHB) genes, estimated at several million base 
pairs in size (Glaser et al. 1986; Porteous et al. 1987). 
We have used a bank of 31 probes and six reference 
loci to divide the WAGR region into 16 intervals, each 
defined by one or more deletion boundaries. The 
aniridia subregion of the WAGR complex locus has been 
identified, and the region proximal to this locus, which 
contains the Wilms tumor gene, has been defined by 
a number of conserved-sequence DNA probes. 
Material and Methods 
Cell Lines, DNAs, and Probes 
Lymphoblastoid celllines GM5518, GM6803, GM-
7736, and GM8785 and fibroblast celllines GM3118, 
GM3808, and GM5296 were obtained from the Insti-
tute for Medical Research, Camden, NJ. Somatic cell 
hybrid lines for chromosomal mapping of DNA probes 
to chromosome 11 have been desaibed elsewhere (Bruns 
et al. 1979). The deletions in the N.W., M.J., and DAR 
hybrid celllines (Bruns et al. 1984; Turleau et al. 1984) 
are indicated in table 1. The nondeleted chromosome 
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Table I 
Cell Llnes for the Deletion Analysis of WAGR Probet 
Cell Line Sex Katyotypic Abnormality Phenotypea 
Lymphoblastoid cells:b 
GM 3118 ........... . 





GM 5296 ........... . 
F 
M 
F inv ins (10;11)(1lpter > llp13:: 
10ql1 > 10ql4::11p13 > 11qter) Coloboma right iris, microcephaly, 
multiple congenital malformations, 
neonatal death 
GM 5518 ........... . 
GM 6803 ........... . 







GM 8785 ........... . 








A, developmental delay 
A 
Hybrid cells: 
N.W ................ . 








WG DAR ............... . 
Leukocytes: 
BC ................. . 








a W,A,G and R = Wilms tumor, aniridia, genitourinary anomalies, and mental retardation, respectively. 
b Information for GM celllines was taken from the NIGMS catalog, 1986 ed. 
c No information on mental status was available on this individual. 
d Camplex rearrangement of 9 and 11, resulting in a net deletion of llp14-p1l (de Martinville and Francke 1983). 
11 homologues were not present in these three hybrids. 
Cellline D.G.85 had been established from patient IV-4 
of Moore et al. (198 6). After informed consent was ob-
tained, peripheral blood leukocytes for DNA isolation 
were obtained from C.L. (Russell and Weisskopf 1986) 
and from BC {table 1). 
The catalase cDNA clone C2-2 containing a 2.0-kb 
insert has been described elsewhere (Bruns et al. 1984 ). 
Probe p58-1 (HVB51; Rogler et al. 1985) was provided 
by Dr. Rogler. Probes ]19.4 (D11517; Housman et al. 
1985) and E51-2 (D1159; Gusella et al. 1980) were ob-
tained from D. 5. Gerhard. The 0.5-kb Hincii/Sacl frag-
ment of pR51.2 (Watkins et al. 1987) was used as a 
probe for F5HB. Plasmid p32-1 (D11516; Feder et al. 
1985) was obtained from the ATCC, Rockville, MD. 
Isolotion of Rondom DNA Probes 
The complete Hindill-digest Charon 21A library of 
ftow-sorted chromosomes 11 of the National Gene Li-
brary Project (LL11N501) was used as a source for ran-
dom clones. Two hundred clones were isolated that hy-
bridized with labeled total human DNA (Gusella et al. 
1980), and phage DNA was prepared according to the 
method of Helmset al. (1985). Inserts were labeled by 
hexanucleotide priming ( Feinberg and Vogelstein 1984) 
and were preannealed with an excess of sheared placen-
tal DNA (Sealey et al. 1985) before being hybridized 
against hybrid cell mapping panels. Of those inserts 
giving adequate signal in the first round of Screening, 
10 were absent from the N.W. deletionhybrid but were 
present in two cell lines containing normal chromo-
somes 11. Phage inserts were subcloned into pU09 to 
facilitate the search for unique fragments which were 
then used to verify the chromosome assignment with 
a )arger panel of hybrid cells that had chromosome 11 
as the sole shared human chromosome. 
The Eagl end-fragment library was prepared in 
EMBL6 phage (Frischauf et al. 1987) from DNA of 
a human-hamster somatic cell hybrid line which con-
tains human chromosomes 11 and X in nearly all cells, 
plus chromosomes 6 and 12 in a fraction of cells. Three 
aliquots of 5 J.Lg DNA were digested with Eagl and one 
of the enzymes BamHI, Bgni or Ben, which give BamHI-
compatible ends. Afterphosphatase treatment, phenol 
extraction and dialysis, 0. 7 J.Lg of insert DNA were 
Iigated with 1 J.Lg of EMBL6 DNA, which had been 
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cut with the enzymes Notl, BamHf, and EcoRI. In vitro 
packaging with Gigapack Plus (Stratagene, La jolla) 
resulted in a library of 20,000 independent clones on 
E. coli strain P2392. Aliquots of the library were plated 
at low density and were screened with radiolabeled hu-
man DNA. Positive clones were rescreened for the ab-
sence of hamster repetitive elements, and phage DNA 
was prepared. Inserts were released by Sall cleavage and 
were isolated from low-melting-point agarose gels. 
Chromosomal mapping and subsequent subdoning 
were done as described for Charon 21A clones. 
DNA E.xtraction 
Cultured cells were washed twice in ice-cold PBS and 
were resuspended in Iysis buffer (70 mM NaCI; 10 mM 
Tris-HCI, pH8; 20 mM Na2EDTA). After addition of 
SDS to 0.2% and proteinase K (100 Jlg/ml), the mix-
ture was incubated at 50°C overnight. Nudeic acids 
were purified by repeated phenol and chloroform ex-
tractions followed by isopropanol precipitation. DNA 
threads were spooled out, washed in ethanol, and 
resuspended in TE bufferat 0.2-0.6 mg/ml. DNA from 
peripheral blood Jeukocytes was isolated according to 
a method described by Kunkel et al. (1982). 
Preparation o( Gene Dosage ßlots 
DNA wasdigested at 0.1 J~g/Jll with EcoRI (10 U/JJg) 
for at least 4 h. DNA concentrations of each sample 
were measured spectroßuorometrically (Brunk et al. 
1979) after completion of the digest. Aliquots of 3.5 
J.Lg of each DNA sample were loaded on a 0. 7% agarose 
gel and were separated overnight at 45 V. Equalload-
ing was again checked by comparison of ethidium bro-
mide staining, and DNA was transferred to GeneScreen 
membranes (New England Nudear, Boston) by alka-
line blotting with 0.5 N NaOH, 1.5 M NaCl. Sub-
sequently, filters were neutralized in 50 mM sodium 
phosphate pH 7.2 (1 M sodium phosphate is 134 g 
Na2HP04 · 7 H20 and 4 ml phosphoric acid/liter), 
and DNA was fixed by baking and UV cross-linking 
(Church and Gilbert 1984). 
Hybridization and Washin( Conditions 
Filters were prehybridized in 1 M NaCI, 50 mM so-
dium phosphate pH 7.2, 50 mM Tris-HCI pH 7.5, 
1 mM Na2EDTA, 1% SDS, 50 Jtg salmon sperm DNA/ 
ml at 65°C for 1 h. DNA probes labeled by hexamer 
priming ( Feinberg and Vogelstein 1984) were added, 
and hybridization was carried out ovemight. After wash-
ing in 40 mM sodium phosphate pH 7 .2, 1% SDS at 
65°C for at least 1 h with three changes of washing 
Gessler et al. 
solution, the filters were exposed to Kodak XAR-5 film 
with an intensifying screen for 12-36 h. Before reprob-
ing was undertaken, the filters were stripped by incubat-
ing in 0.1 x TE, 0.1% SDS at 75-80°C for 30 min. 
Gene Dosage Analysis 
Throughout the study, DNA samples from several 
different lymphoblastoid celllines of normal individu-
als were used as controls on every filter. Hybridization 
signals foreachprobe were evaluated independently by 
two investigators. After visual comparison of signal 
strength, the relative band intensities were measured 
with an LKB Iaser scanning densitometer. Every filter 
was repeatedly hybridized with probes from within and 
outside the deletions to obtain reference signals. On 
several gels additional lanes were loaded with 50% of 
the normal amount of control DNA to provide addi-
tional standards for 2:1 dosage. 
Results 
The Probe Bank o( the WAGR Deletion Region 
Ten chromosome 11 probes that mapped within the 
N.W. WAGR deletion were derived by screening 200 
random clones with human inserts from the LL11NS01 
ßow-sorted chromosome 11 library. Chromosome 11 
assignment of the probes was established by hybridiza-
tion with a DNA mapping panel of seven independent 
hybrid dones that had chromosome 11 as their only 
shared human chromosome (Bruns et al. 1979; Davis 
et al. 1986). Fifteen of the WAGR deletion dones used 
in the present study had been generated by prior analy-
sis of 300 human clones from the LL11NS01 library 
(Bruns et al. 1987). 
To increase the probability of isolating probes in the 
vicinity of genes, an Eagl end-fragment library was con-
structed in the vector EMBL6 by using DNA from a 
human-hamster hybrid that contained mainly human 
chromosomes 11 and X. The use of the enzyme Eagl 
for construction of the library should bias the represen-
tation in favor of CpG-rich islands, which are located 
at the 5' end of a number of expressed sequences (Brown 
and Bird 1986). Of 200 human DNA-containing phage 
inserts screened, four could be assigned to the chromo-
some 11 deletion region of N .W. 
Of the 29 probes deleted from one chromosome 11 
homologue of N.W. isolated by screening random dones 
from the ßow-sorted and hybrid cell chromosome 11 
libraries, 23 could be sublocalized to a smaller deletion 
found in an individual with Wilms tumor, aniridia, and 
mental retardation (M.J.; table 1). Two additional probes 
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(J77-PH and J77-2.3X) that map within the N.W. de-
letion were derived from cloning an AGR deletion break-
point (Gessler and Bruns 1988). 
The CAT L.ocus and Proximal Probes 
To subdivide and further characterize the area cov-
ered by the N.W. and M.J. deletions, DNAs from cell 
lines or from leukocytes of a number of individuals with 
either the WAGR syndrome or a related phenotype were 
analyzed. Cytogenetic deletions or other rearrangements 
had been described for all the individuals (table 1). To 
detect these heterozygous deletions, gene dosage blots 
were prepared and were hybridized with the probe bank 
described above, together with suitable controls. 
The catalase gene had previously been used as a 
marker for chromosome llp13 and was shown to be 
centromeric to the M.J. deletion but within the larger 
N.W. deletion (Glaser et al. 1986). Enzyme analysis 
had already suggested a heterozygous deletion of the 
catalase genein GM5296, GM5518, and GM6803 (In-
stitute ofMedical Research Catalogue, 1986 ed.). These 
findings are supponed by the results of gene dosage 
analysis with the catalase cDNA probe. All celllines 
analyzed in figure 1A shows a diminished hybridiza-
tion signal with this probe when compared with con-
trol DNA. Densitometric scanning revealed a reduc-
tion in signal intensity of about 50%, suggesting the 
CAT 
8 
+ + + 
489 
loss of one copy of the gene in all celllines. Rehybridi:. 
zation of the same filter with a non-chromosome 11 
probe (N76) confirmed equalloading of the lanes (fig. 
1B). With the exception of M.J. and BC, all the cytoge-
netically described deletions, as weilasthat in GM5296, 
included the catalase gene (fig. 2). This was also seen 
with probe 277. 
The centromeric part of the N .W. deletion that is not 
deleted in M.J. could be split into four intervals. The 
mapping and cloning of the proximal breakpoint in 
GM7736 (Gessler and Bruns 1988) allowed the first 
subdivision with probes 277, 575, J77-PH, and CAT 
located telomeric to the breakpoint (fig. 2). This inter-
val was further broken up by the proximal breakpoint 
in GM3808, as only probes 575 andJ77-PH were pres-
ent on both chromosome 11 homologues in this cell 
line. The interval between the GM7736 and N.W. break-
points was finally split by the proximal end of the 
GM8785 deletion, with probe 508 being the most prox-
imal marker in the N .W. deletion and probe 540 being 
located closer to the GM7736 breakpoint. 
The positioning of these probes on the proximal side 
of the M.J. deletion was confirmed by dosage analysis 
of GM3118. The deletion in this cellline partially over-
laps the M.J. deletion but extends even moreproximal 
than the N.W. hreakpoint and includes the marker 




- - #582 
----
- - E136 
c 
+ + + + + 
+ + + + + + 
+ 
+ + + + + 
Fi1ure I Gene dosage analysis with WAGR deletion probes. A Southem 6Jter prepared with 3.5 pg DNA from different celllines 
in each lane was sequentially hybridized with the catalase cDNA probe (A), probes 475 and N76 (B), and probes 582 and El36 (C). Probe 
N76, which is not derived from chromosome 11, gave an approximately 1:1 ratio of signal strength between test sample and control DNA 
for all celllines analyzed. Symbols below the autoradiograms are defined as follows: + = Both alleles present in that particular cellline; 
- = reduction to a 0.5:1 ratio in signal intensity, indicative of a heterozygous deletion with one allele remaining. 
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Flgure 2 Deletion map of the WAGR region. Probes are listed 
in a linear order from the most telomeric to D11S9 on the centro-
meric side. The bars indicate the presence of the respective set of 
probes. Empty spaces delineate areas of heterozygous deletion. Con-
served probes that hybridize to rodent DNA at high stringency are 
marked by an asterisk (•). 
these proximal intervals were heterozygously deleted 
in GM3118, as expected. 
The M.J. deletion could be shown to be completely 
contained within the larger N .W. deletion. Probes 109 
and 113 are present on both homologues in GM3118, 
as well as in M.J., but are absent from one N.W. homo-
logue. They define, therefore, a new interval distal to 
the M.J. deletion but within the N.W. deletion (fig. 2). 
This interval is split by the telomeric breakpoint of the 
BC deletion which falls between these probes. Only two 
of the deletions analyzed (GM3808 and GM5518) ex-
tended more telomeric on 11p as judged by gene dosage 
analysis for the D11S17 marker which had been shown 
to be outside and distal to the N .W. deletion (Glaser 
et al. 1986). 
Definition of lntervols within the M.). Deletion 
The breakpoints of nine cytogenetically defined chro-
mosomal rearrangements could be localized within the 
M.J. 'deletion. The mapping and cloning of the GM7736 
deletion breakpoints, defined by probe 164, has been 
Gessler et al. 
described elsewhere (Gessler and Bruns i988). Three 
additional probes-25, E136, and HVBS1 (figs. 1C, 
2)- arenot deleted in GM7736 and therefore map dis-
tal to probe 164. All other probes assigned to the M.J. 
deletion region are absent from one chromosome 11 
homologue of GM7736 (figs. 1b, lc, 3 ). 
The next proximal interval is defined by GM6803, 
where two additional probes (181 and 475) did not show 
reduced dosage. The celllines GM3118 and GM8785 
mark the only instance where two deletion breakpoints 
within the region defined by the M.J. deletion have not 
yet been resolved. Probes 181, 475, and 514 arenot 
included in both deletions (figs. 1B, 2). Asprobe 514 
was absent from one chromosome 11 homologue in 
GM6803, the breakpoints in GM3118 and GM8785 
can be placed proximal to the GM6803 deletion 
boundary. 
Seventeen of our probes then remained localized to 
the M.J. deletion but were absent in all the cytogeneti-
cally described deletions initially tested. A further sub-
divisionwas possible with GM5296. This cellline was 
described as an insertion of 10q21-q24 into 11p13. The 
reduced red blood cell catalase activity in the individual 
from whom the cell line was derived suggested a loss 
-#239 





Flpre 3 Gene dosage analysis with probes from the proximal 
pan of the M.J. deletion region. Probe 257 is heterozygously deleted 
in aU celllines (- ). For probe 239, three celllines show delerion 
of one allele. 
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of material from chromosome 11. Furthermore all of 
the probes mapping to the N.W. deletion region prox-
imal to the M.J. breakpoint showed reduced dosage in 
this cellline, indicating a substantial deletion. The dis-
tal end of this deletion allowed us to subdivide the large 
interval between the GM3118/GM8785 and MJ. break-
points. Eight of the 17 probes assigned to this area were 
included in the GM5296 deletion (figs. 1-3) and are 
therefore located on the centromeric side of this inter-
val. The interval could be further subdivided when leu-
kocyte DNA from patient C.L. was analyzed. Five 
probes, together with the markers FSHB and D11S16, 
were present on both chromosome 11 homologues in 
this individual, whereas probes 403,495,570, and 582 
and a number of centromeric probes were heterozy-
gously deleted (figs. 2, 4a). The distal boundaries of 
the GM5296 and C.L. deletions, therefore, divide the 
critical region of overlap of the WAGR deletions into 
three intervals. A fourth interval on the proximal side 
of the overlap region, defined by probe E97, was 
identified by analysis of leukocyte DNA from BC, a 
male child with genitourinary anomalies, aniridia, and 
a llp14-p13 deletion (fig. 4b). Seven ofthe eight probes 
between the GM5296 and M.J. breakpoints were het-
erozygously deleted, as weil as all telomeric probes tested 
(fig. 2). 
Chromosomal Deletions De(ining Probes (or the Wilms 
Tumor ond Aniridio Genes 
In one kindred with heritable isolated aniridia, the 
defect was associated with the chromosome transloca-
tion t(l1;22) (p13;q12.2) (Moore et al. 1986). As re-
ported by Davis et al. (1988), this translocation is as-
sociated with a cytogenetically undetectable deletion 
of sequences from chromosome 11. Analysis of a cell 
line from one individual of this family (D.G.85) revealed 
that probes 403, 495, and 582 are heterozygously 
deleted (figs. 2, 5). Earlier analysis of another chromo-
some 11 translocation associated with familial aniridia 
had localized the FSHB gene distal to the breakpoint 
and the presumptive gene (Glaser et al. 1986). This 
would then put probes 403, 49 5, and 582 centromeric 
to FSHB. The same order was derived &om analysis 
of the C.L. deletion. Pulsed-field gel analysis with probes 
surrounding FSHB (Gessler and Bruns, submitted) has 
shown that probe 570 must be located telomeric to those 
deleted in D.G.85, thereby establishing an additional 
interval defined by probe 570 between the D.G.85 dele-
tion and the distal breakpoint in C.L. 
The chromosomal region for the Wilms tumor gene 
was defined using the hybrid cellline DAR which con-
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Fipre 4 Gene dosage analysis of leukocyte DNA from pa-
tients C.L. (a) and BC (b). Probes Dl1S16 and 570 were used for 
C.L. DNA with control DNA (C) run on both sides. Control sam-
ples for the analysis ofBC. DNA were normallymphoblastoid DNA 
(C) and DNA from a fibroblast cellline of M.J. in which a deletion 
of probes E97 and E61 &om one chromosome 11 homologue had 
been shown by somatic ceU hybrid analysis. Probe 277 shaws an RFLP 
with the enzyme EcoRI. The presence of both or only one allele for 
each probe is indicated by ( +) and (- ), respectil'ely. 
tains the deleted chromosome 11 of an individual with 
Wilms tumor but not aniridia (Turleau et al. 1984; 
Couillin et al., submitted). All of our probes mapping 
proximal to the D.G.85 deletion were absent in DAR. 
Eight probes, five of which detect conserved sequences 
in hamster or mouse DNA, are deleted bothin DAR 
and in the M.J. hybrid cellline. As both individuals 
had Wilms tumor, all probes from the overlap region 
of the M.J. and DAR deletions arepotential candidate 
clones to define the Wilms tumor locus. 
Discussion 
Mapping of random phage clones against hybrid 
panels containing WAGR deletion chromosomes has 
allowed us to develop a large probe bank for this re-
gion. Twenty-nine new probes covering the area from 
proximal llp14 to distal llp12 have been isolated in 
this way. Twenty-three of these could be sublocalized 
to a smaller deletion which does not include the cata-
lase gene. 
Eight cell lines with cytogenetically detected chro-
mosome 11p rearrangements, most of them deletions, 
together with three hybrid celllines and two leukocyte 
DNA samples from individuals with WAGR-related de-
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Flgure 5 Gene dosage analysis of D.G. 85. A, EcoRI-digested DNA from D.G. 85 (middle lane) and from two control samples was 
analyzed with probes 582 and E136. B, Densitometric scanning of the autoradiogram revealed a signal intensity ratio of 0.43:1 for probe 
582 when D.G. 85 (dashed line) was compared with controllanes (solid line). 
letions, were studied by gene dosage analysis. Every cell 
line showed reduced dosage, indicative of a heterozy-
gous deletion, for at least some of the probes tested. 
A different subset of the probe bank, however, was 
affected in each cell line. These partially overlapping 
deletions allowed us to subdivide the WAGR region of 
chromosome 11 into 16 intervals, extending from band 
p14 to band p12. Nearly all of the breakpoints were 
found to be staggered and set apart from each other 
by at least one probe. This observation argues against 
the involvement of a major recombination hot spot in 
the induction of these rearrangements. 
In related studies, Porteous et al. {1987) and Bick-
more et al. {198 8) have divided the region between mid-
11p14 and proximal11p12 into seven intervals, two of 
which fall between FSHB and CAT. The subdivision 
of the WAGR region into 16 intervals in the present 
study, including five subregions in the overlap area neces-
sary for the pathognomonic features of the syndrome, 
provides a framework map for the molecular, physical, 
and genetic analysis of this region. Although specific 
phenotypes have not yet been associated with deletion 
subregions beyond the critical region, definition of six 
intervals above and five intervals below the overlap area 
may permit identification of subtle phenotypic features 
in individual patients. 
The relative extent of the deletions as analyzed by 
our dosage studies was in agreement with the cyto-
genetic description in most of the cases. In GM5296, 
which contains a chromosomal insertion into 11p13, 
a cytogenetically undetected deletion had been postu-
lated from the analysis of catalase activity. This dele-
tion could be verified by gene dosage analysis with a 
catalase cDNA clone. The absence of a number of ad-
ditional probes from one chromosome 11 homologue 
of this cellline even suggests that this deletion is of con-
siderable size. Probes close to the breakpoints of com-
plex rearrangements, suchasthat in GM5296, offer 
a direct route to identify their exact molecular compo-
sition by high-resolution in situ hybridization. 
A smaller deletion, including only three of the probes, 
was found in the cellline of an individual with t{11;22) 
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(p12;q12.2), associated with heritable aniridia. A simi-
lar observation has recently been published by Davis 
et al. (1988). These probes are important markers for 
localizing the aniridia gene, which should be within 
the deletion or very dose to the chromosome break-
points. Determination of the relationship between the 
breakpoints of this deletion and that of a second trans-
location, also associated with familial aniridia (Simola 
et al. 1983 ), may Iead to the identification of the gene. 
The deletion region common to the M.J. and DAR 
hybrid celllines provides the smallest region of overlap 
for the Wilms tumor locus. Eight of our probes map 
to this interval, and five of these eight detect conserved 
sequences in hamster or mouse DNA. They may, there-
fore, contain parts of coding sequences. The use of these 
probes in analysis of DNAs from Wilms tumors may 
pinpoint this gene. Probe E97 was not induded in the 
deletion found in BC, which restricts the interval for 
the gene causing anomalies of the genitourinary tract 
tothat between the BC and DAR breakpoints. This does 
not necessarily exdude probe E97 from the Wilms tu-
mor region, although Wilms tumor and genitourinary 
anomalies have been postulated to result from different 
events at the same locus (Porteous et al. 1987). Although 
several deletions with centromeric boundaries proximal 
to CAT have been described in females (Glaser et al. 
1986; Compton et al. 1987; Porteous et al. 1987), only 
one, the RIST deletion, has been reported in a male 
(Davis et al. 1988 ). As urinary-tract anomalies are of-
ten not conspicuous in females, the BC deletion defines 
for the firsttime a proximal Iimit for the GU subregion 
of WAGR deletions. 
Evidence for the localization of the gene causing men-
tal retardation in WAGR patients may come from anal-
ysis of the deletion in C.L., who had aniridia and Wilms 
tumor together with a cytogenetic deletion of 11p13, 
butwho showed average intelligence (Russell and Weiss-
kopf 1986). The deletion in this case extends more prox-
imal than do those in M.J., GM7736, and GM8785, 
aJl of which are associated with mental retardation, but 
it does not extend far on the telomeric side. Similarly, 
the DAR deletion, which also is extensive on the cen-
tromeric side, was not associated with mental retarda-
tion (Turleau et al. 1984 ). By contrast, the deletions 
in the GM8785 and GM6803 celllines were reported 
to be associated with developmental delay in a 5-mo-
old child and with frank mental retardation, respec-
tively. We soggest, therefore, that the locus for mental 
retardation may be between the distal breakpoint of 
the C.L. deletion and the proximal boundaries of the 
GM8785 and GM6803 deletions. Definition of the rela-
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tionship between telomeric extent and the presence or 
absence of mental retardation for additional deletions 
wi]] be necessary to evaluate this model. 
In addition to defining the WAGR gene loci, this high-
resolution map derived from our gene dosage studies 
will also serve as an invaluable tool for the analysis of 
any new WAGR-related deletion. All additional break-
points can now be mapped more precisely and can be 
localized relative to breakpoints described in the pres-
ent study. A number of these breakpointswill be dose 
enough to our probes to permit molecular doning, 
thereby providing insight into the mechanisms induc-
ing these rearrangements. The high density of probes 
will also make it possible to develop a continuous long-
range restriction map of this region. Given an estimated 
10 Mbp size for the N.W. deletion, the average distance 
between probes will be on the order of only a few hun-
dred kilobase pairs. 
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